1. O-glycosylation in liver cancer: Clinical associations and potential mechanisms
    Kung-Hao Liang et al, 2017, Liver Research CrossRef
  2. Prognostic profile of patients with non‑viral hepatocellular carcinoma: A comparative study with hepatitis C virus‑related hepatocellular carcinoma using data mining analysis
    Yu Noda et al, 2019, Oncology Letters CrossRef
  3. GALNT14 genotype is associated with perineural invasion, lymph node metastasis and overall survival in resected cholangiocarcinoma
    Kung-Hao Liang et al, 2017, Oncology Letters CrossRef
  4. GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization
    Kung-Hao Liang et al, 2016, Pharmacogenomics CrossRef
  5. GALNT14 genotype as a response predictor for concurrent chemoradiotherapy in advanced esophageal squamous cell carcinoma
    Yung-Kuan Tsou et al, 2017, Oncotarget CrossRef
  6. Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma
    Kung-Hao Liang et al, 2021, Biomedicines CrossRef
  7. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy
    Wey-Ran Lin et al, 2016, Medicine CrossRef
  8. MiR-125a regulates ovarian cancer proliferation and invasion by repressing GALNT14 expression
    Juan Yang et al, 2016, Biomedicine & Pharmacotherapy CrossRef
  9. Rs9679162 genotype predicts prognosis of real-world advanced hepatocellular carcinoma treated by sorafenib
    Chih-Lang Lin et al, 2023, Cancer Biomarkers CrossRef
  10. The Role of Glycans in Chronic Inflammatory Gastrointestinal and Liver Disorders and Cancer
    Ângela Fernandes et al, 2021, Comprehensive Glycoscience CrossRef
  11. GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial
    Wei-Ting Chen et al, 2022, Hepatology International CrossRef
  12. GALNT14: An Emerging Marker Capable of Predicting Therapeutic Outcomes in Multiple Cancers
    Wey-Ran Lin et al, 2020, International Journal of Molecular Sciences CrossRef